(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 27.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.62%.
Ekso Bionics Holdings's earnings in 2025 is -$10,434,000.On average, 4 Wall Street analysts forecast EKSO's earnings for 2025 to be -$9,150,886, with the lowest EKSO earnings forecast at -$8,792,028, and the highest EKSO earnings forecast at -$9,420,030. On average, 4 Wall Street analysts forecast EKSO's earnings for 2026 to be -$1,926,502, with the lowest EKSO earnings forecast at -$1,850,953, and the highest EKSO earnings forecast at -$1,983,164.
In 2027, EKSO is forecast to generate -$5,217,610 in earnings, with the lowest earnings forecast at -$5,012,998 and the highest earnings forecast at -$5,371,070.